human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) Report issue

Vaccine Approved FDA
AACT PubChem

Active Ingredient History

NOW
  • Now
Human papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HPV types 16 and 18, which cause the greatest risk of cervical cancer. It is estimated that HPV vaccines may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and show more than 90% efficacy in preventing HPV-positive oropharyngeal cancers. They additionally prevent some genital warts, with the quadrivalent and nonavalent vaccines that protect against HPV types HPV-6 and HPV-11 providing greater protection.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

4-valent hpv vaccine | both doses late | gardasil | hpv vaccine | human papillomavirus 6,11,16,18 vaccine | human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant | human papillomavirus quadrivalent vaccine | human papillomavirus type 11 l1 protein /human papillomavirus type 16 l1 protein /human papillomavirus type 18 l1 protein/human papillomavirus type 6 l1 protein | human papillomavirus type 6 l1 protein / human papillomavirus type 11 l1 protein / human papillomavirus type 16 l1 protein / human papillomavirus type 18 l1 protein | human papillomavirus vaccine l1, type 6,11,16,18 | quadrivalen human papillomavirus vaccine | quadrivalent human papillomavirus vaccine | silgard | tetravalent vaccine | v501

Organizations (123)

Research & Development (123)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (56)

Approved Indications (1)


 

Papillomavirus Vaccines (approved 2006)

Experimental Indications - Clinical Trial Phases 1-4 (56)


 

Acne Vulgaris (Phase 2)

Adenocarcinoma in Situ (Phase 4)

Alphapapillomavirus (Phase 4)

Androgens (Phase 3)

Anus Neoplasms (Phase 2)

Arthritis, Juvenile (Phase 3)

Autoimmune Diseases (Phase 3)

Bone Marrow Transplantation (Phase 3)

Cancer Survivors (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 4)

Condylomata Acuminata (Phase 4)

Diphtheria (Phase 3)

Drugs, Investigational (Phase 2)

Genital Diseases, Female (Phase 2)

Healthy Volunteers (Phase 4)

Hematopoietic Stem Cell Transplantation (Phase 1)

HIV (Phase 4)

HIV Infections (Phase 3)

Human papillomavirus 16 (Phase 4)

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (Phase 3)

Humans (Phase 3)

Immune System Diseases (Phase 2)

Infections (Phase 4)

Inflammatory Bowel Diseases (Phase 3)

Kidney Transplantation (Phase 4)

Liver Transplantation (Phase 4)

Lung Diseases (Phase 3)

Lupus Erythematosus, Systemic (Phase 4)

Meningitis (Phase 3)

Meningitis, Meningococcal (Phase 4)

Meningococcal Infections (Phase 2)

Meningococcal Vaccines (Phase 2)

Neoplasms (Phase 4)

Neoplasms, Glandular and Epithelial (Phase 3)

Papilloma (Phase 4)

Papillomaviridae (Phase 3)

Papillomavirus Infections (Phase 4)

Papillomavirus Vaccines (Phase 4)

Penile Neoplasms (Phase 2)

Pharmacological and Toxicological Phenomena (Phase 1)

Poliomyelitis (Phase 3)

Precancerous Conditions (Phase 4)

Sexually Transmitted Diseases (Phase 2)

Tetanus (Phase 3)

Transplantation (Phase 2)

Transplants (Phase 3)

Uterine Cervical Dysplasia (Phase 1)

Uterine Cervical Neoplasms (Phase 4)

Vaccine-Preventable Diseases (Phase 4)

Vaccines (Phase 2)

Vaginal Neoplasms (Phase 3)

Vulvar Neoplasms (Phase 3)

Warts (Phase 4)

Whooping Cough (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 116
  • # of Trial Organizations: 123

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue